# Marfan syndrome

Condition · id `cardio:marfan-syndrome` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Marfan's syndrome; MFS

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

Marfan syndrome is a genetic disorder of connective tissue, the proteins that support the skin, bones, blood vessels and other organs. A problem with the fibrillin gene causes it, and it can affect the heart, the eyes and the skeleton. Most people with Marfan syndrome have heart and blood vessel problems, such as a weakness in the aorta or leaking heart valves. The aorta can weaken and stretch into a bulge (aneurysm) or tear (dissection), which can be life threatening. Marfan syndrome can be mild to severe. It has no cure, but treatments can help delay or prevent complications.

## Technical summary

MeSH descriptor D008382 (Marfan Syndrome). Its scope note calls it an autosomal dominant disorder of connective tissue with abnormal features in the heart, the eye and the skeleton, lists mitral valve prolapse, aortic aneurysm and aortic dissection as cardiovascular manifestations, and ties type 1 to mutations in the gene encoding fibrillin-1 (FBN1). A US government genetics page gives an incidence of approximately 1 in 5,000 worldwide, says the condition is inherited in an autosomal dominant pattern, and says at least 25 percent of cases result from a new mutation in the FBN1 gene. A US government patient page says there is no specific test, that treatments include medicines, surgery and other therapies, and that a doctor may use the medical history, family history and a physical exam to diagnose it. The text rests on the MeSH scope note, that genetics page and that patient page.

## Connected pages

- Filed under this front: Medicines (`cardio:front-medicines`)
- Related condition: Heart valve disease (`cardio:heart-valve-disease`)
- Repair of an aortic aneurysm: Aortic aneurysm repair (open surgery, EVAR, TEVAR) (`cardio:aortic-aneurysm-repair-open-surgery-evar-tevar`)
- Related to: Aortic dissection (`cardio:aortic-dissection`)
- Related to: Cervical artery dissection (`cardio:cervical-artery-dissection`)
- Related to: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 3 registry trials

## Provenance

Content hash: 62e394b20dbb82117ca4bf16d1949aa3649008b1bf3bbae1295b3a02e416233d
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
